Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
CMB.TECH NV (CMBT) Q4 2025 Earnings Call Transcript
12:57pm, Thursday, 26'th Feb 2026
CMB.TECH NV (CMBT) Q4 2025 Earnings Call Transcript
CMB.TECH ANNOUNCES Q4 2025 RESULTS - EIGHT VLCCS SOLD AT STELLAR PRICES
01:01am, Thursday, 26'th Feb 2026
CMB.TECH ANNOUNCES Q4 2025 RESULTS EIGHT VLCCS SOLD AT STELLAR PRICES ANTWERP, Belgium, 26 February 2026 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE: CMBT, Euronext Brussel
Bio-Techne to Present at Upcoming Investor Conferences
07:00am, Tuesday, 24'th Feb 2026
MINNEAPOLIS, Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: TD Cowen 46th Annual Health Care Conference
Bio-Techne Corp $TECH Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A.
04:08am, Saturday, 21'st Feb 2026
BNP PARIBAS ASSET MANAGEMENT Holding S.A. lowered its position in Bio-Techne Corp (NASDAQ: TECH) by 95.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exc
KMDA or TECH: Which Is the Better Value Stock Right Now?
12:40pm, Tuesday, 17'th Feb 2026
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Techne (TECH). But which of these two stocks presents investors with the better value opport
Ella benchtop instrument is now CE-IVD marked and available for sale in the EU Enables diagnostic assay developers to leverage a simplified platform that delivers speed and reproducible results with m
Caprock Group LLC Takes $1.71 Million Position in Bio-Techne Corp $TECH
03:49am, Saturday, 14'th Feb 2026
Caprock Group LLC purchased a new position in Bio-Techne Corp (NASDAQ: TECH) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). Th
CMB.TECH ANNOUNCES Q4 2025 RESULTS ON 26/02/2026
02:15am, Thursday, 12'th Feb 2026
Antwerp, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) will release its fourth quarter 202 5 earnings prior to m
Bio-Techne Announces Changes to its Leadership Team
09:00am, Wednesday, 11'th Feb 2026
Dr. Matt McManus to transition from his role as President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 Steve Crouse, Senior Vice President of Bio-Techne's Analytical Solutions Div
Baader Bank Aktiengesellschaft Buys 38,082 Shares of Bio-Techne Corp $TECH
04:22am, Wednesday, 11'th Feb 2026
Baader Bank Aktiengesellschaft boosted its stake in shares of Bio-Techne Corp (NASDAQ: TECH) by 57.9% during the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned
CMB.TECH FLEET UPDATE
02:16am, Monday, 09'th Feb 2026
Antwerp, Feb. 09, 2026 (GLOBE NEWSWIRE) -- CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs : CMBTO) has sold two ve
Bio-Techne (NASDAQ:TECH) Trading Up 7% on Strong Earnings
02:58am, Thursday, 05'th Feb 2026
Shares of Bio-Techne Corp (NASDAQ: TECH - Get Free Report) shot up 7% on Wednesday following a better than expected earnings announcement. The company traded as high as $69.92 and last traded at $69.1
Bio-Techne Corp (TECH) Q2 2026 Earnings Call Highlights: Strategic Growth and Margin Expansion Amidst Revenue Challenges
04:01pm, Wednesday, 04'th Feb 2026
Adjusted EPS: $0.46, up 10% year-over-year.GAAP EPS: $0.24, up from $0.22 in the prior year period.Total Revenue: $295.9 million, flat year-over-year on both a
Bio-Techne Corporation (TECH) Q2 2026 Earnings Call Transcript
01:30pm, Wednesday, 04'th Feb 2026
Bio-Techne Corporation (TECH) Q2 2026 Earnings Call Transcript
TECH Q2 Earnings & Revenues Beat Estimates, Operating Margin Up
10:36am, Wednesday, 04'th Feb 2026
Bio-Techne tops Q2 EPS and revenue estimates as operating margin jumps 244 bps, even with flat organic sales and a slight year-over-year revenue dip.
